Search alternatives:
significant proteomic » significant economic (Expand Search), significant potential (Expand Search), significant promise (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
proteomic decrease » proteomic database (Expand Search)
significant proteomic » significant economic (Expand Search), significant potential (Expand Search), significant promise (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
proteomic decrease » proteomic database (Expand Search)
-
2001
-
2002
-
2003
-
2004
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2005
-
2006
-
2007
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2008
-
2009
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2010
-
2011
-
2012
-
2013
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2014
-
2015
-
2016
-
2017
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2018
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2019
-
2020